These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2067097)

  • 21. Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout).
    Becker MA
    Rheum Dis Clin North Am; 1988 Aug; 14(2):377-94. PubMed ID: 3051156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial occurrence of hyperuricemia, gout, and medullary cystic disease.
    Thompson GR; Weiss JJ; Goldman RT; Rigg GA
    Arch Intern Med; 1978 Nov; 138(11):1614-7. PubMed ID: 718310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gout in young patients].
    Henninges D; Mertz DP
    Cah Med; 1971 May; 12(7):539-43. PubMed ID: 5562273
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical findings and therapy of gout with special reference to the metabolic effects of sulfinpyrazone (Anturan) and allopurinol (Zyloric)].
    Günther R; Knapp E
    Wien Klin Wochenschr; 1969 Nov; 81(45):817-20. PubMed ID: 5362152
    [No Abstract]   [Full Text] [Related]  

  • 25. [Missed gout].
    Rückert KH; Chowanetz W
    Munch Med Wochenschr; 1972 Apr; 114(14):663-5. PubMed ID: 5067879
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hyperuricemia and gout in childhood (Lesch-Nyhan syndrome)].
    Kölle G
    Med Klin; 1971 Apr; 66(17):626-30. PubMed ID: 4251840
    [No Abstract]   [Full Text] [Related]  

  • 27. [Inhibition of endogenous synthesis of uric acid with allopurinol in patients with gout and urate diathesis].
    Holländer E; Schwarczmann P
    Munch Med Wochenschr; 1969 Aug; 111(32):1623-6. PubMed ID: 5394966
    [No Abstract]   [Full Text] [Related]  

  • 28. [Ocular findings in gout and hyperuricemia].
    Heinz K; Schabel F; Günther R
    Wien Klin Wochenschr; 1971 Jan; 83(3):42-4. PubMed ID: 5547425
    [No Abstract]   [Full Text] [Related]  

  • 29. Altered uric acid levels and disease states.
    Kutzing MK; Firestein BL
    J Pharmacol Exp Ther; 2008 Jan; 324(1):1-7. PubMed ID: 17890445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Calcium antagonists: current and future applications based on new evidence. The mechanisms on lowering serum uric acid level by calcium channel blockers].
    Mizuta E; Hamada T; Igawa O; Shigemasa C; Hisatome I
    Clin Calcium; 2010 Jan; 20(1):45-50. PubMed ID: 20048433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic factors associated with gout and hyperuricemia.
    Bleyer AJ; Hart TC
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):124-30. PubMed ID: 16580613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial hyperuricemia and renal insufficiency.
    Foreman JW; Yudkoff M
    Child Nephrol Urol; 1990; 10(2):115-8. PubMed ID: 2253250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hyperuricemia and gout--diagnosis].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):207-9. PubMed ID: 11821993
    [No Abstract]   [Full Text] [Related]  

  • 34. Does renal impairment protect from gout?
    Youssef P; Brama T; York H; Pickard P; Stewart P; McGill N
    J Rheumatol; 1995 Mar; 22(3):494-6. PubMed ID: 7783068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Familial encephalopathy with hyperuricemia. A study of purine metabolism and therapeutic attempts].
    Labrune B; Cartier P; Bonnenfant F; Ribierre M; Mallet R
    Arch Fr Pediatr; 1969 Feb; 26(2):139-54. PubMed ID: 5375873
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnostic value of renal urate excretion].
    Häntzschel U; Költzsch V
    Z Gesamte Inn Med; 1978 Mar; 33(6):180-4. PubMed ID: 645153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic gouty nephropathy: a vanishing syndrome?
    Reif MC; Constantiner A; Levitt MF
    N Engl J Med; 1981 Feb; 304(9):535-6. PubMed ID: 7453785
    [No Abstract]   [Full Text] [Related]  

  • 38. [The kidneys in gout. Study of their interaction].
    Goy P
    Praxis; 1965 Aug; 54(31):921-5. PubMed ID: 5897487
    [No Abstract]   [Full Text] [Related]  

  • 39. Current and future therapeutic options for the management of gout.
    Whelton A
    Am J Ther; 2010; 17(4):402-17. PubMed ID: 20562597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.